This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated DPT Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-DPT WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~24 kDa | |
| Observed band | ~20 kDa | |
| Gel | 5–20% (catalog A02642-1) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Cleaved | |
| Caveat | Secreted ECM protein | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A02642-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human Hela, human placenta, rat lung (catalog A02642-1) |
| Gel % | 5–20% (catalog A02642-1) |
| Load | 50ug; reducing conditions (catalog A02642-1) |
| Transfer | a Nitrocellulose membrane at 150mA for 50-90 minutes (catalog A02642-1) |
| Membrane | Nitrocellulose membrane (catalog A02642-1) |
| Blocking | 5% Non-fat Milk/ TBS for 1.5 hour at RT (catalog A02642-1) |
| Primary antibody | A02642-1 · 0.5 μg/mL (catalog A02642-1) |
| Primary incubation | overnight at 4°C (catalog A02642-1) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:10000 (catalog A02642-1) |
| Secondary incubation | 1.5 hour at RT (catalog A02642-1) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A02642-1) |
| Detection | ECL (catalog A02642-1) |
DPT is predicted at 24 kDa and observed at ~20 kDa; the cause of the difference is not established.
| Band at ~20 kDa | Empirical DPT band in reducing tissue and cell lysates; its lower migration than predicted is unexplained. |
| Band near 24 kDa | Compatible with the predicted precursor mass; confirm identity with antibody controls. |
| Band below the precursor position | Could reflect signal-peptide removal, but a specific mature mass is not established. |
| Little or no band in whole-cell lysate | DPT is secreted into the extracellular matrix. |
| Predicted precursor mass | Provides a 24 kDa sequence-based reference, not the measured band position. |
| Signal peptide at residues 1–18 | Cleavage can make mature DPT smaller than its precursor; mature migration is not supplied. |
| Pyrrolidone carboxylic acid at residue 19 | Its effect on apparent band size is not established. |
| Sulfotyrosines at residues 23, 162, 164, 166, 167, and 194 | Their effect on apparent band size is not established. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Secreted DPT may be depleted from whole-cell lysate. | Check extracellular matrix or conditioned-medium samples alongside a positive control. |
| Band lower than expected | The observed ~20 kDa band is below the 24 kDa precursor prediction; its cause is unestablished. | Compare with a positive-control sample and confirm antibody specificity. |
| Band higher than expected | An unidentified band may be nonspecific or have altered migration. | Compare with a positive control and use an independent DPT antibody. |
| Multiple bands | Precursor and signal-cleaved DPT are possible, but distinct bands are not established. | Check sample preparation and compare bands using an independent DPT antibody. |
| Weak or no signal | Secreted DPT may be scarce in the sampled fraction. | Enrich extracellular material and include a positive-control sample. |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for DPT, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-DPT antibody, A02642-1, with stated human, mouse, and rat reactivity. Its Western blot image shows a band near 20 kDa versus the expected 24 kDa; the supplied evidence does not establish orthogonal validation.
Which to pick: A02642-1 is the only listed option and has a Western blot image using human HeLa cells and placenta, rat lung, and mouse lung lysates. The caption reports reducing conditions, 50 µg per lane, and 0.5 µg/mL primary antibody.